Prof. Dr. Markus Ketteler | Institut für klinische Pharmakologie IKP

Major Projects

Biobank “Peritonealdialyse) S569-PD, RBK
Peritoneal membrane integrity
Identification of deliverable drugs for treatment of PD patients in clinical practice
Establishment of a directional peritoneal model

Selected References

Ketteler M, Wiecek A, Rosenkranz AR, Ose C, Rekowski J, Lorenz H, Hellmann B, Karus M, Ruhmann M, Ammer R. Modified-release nicotinamide for the treatment of hyperphosphataemia in haemodialysis patients: 52-week efficacy and safety results of the phase III randomised controlled NOPHOS trial. Nephrol Dial Transplant. 2022 Jun 25:gfac206.

Oberacker T, Fritz P, Schanz M, Alscher MD, Ketteler M, Schricker S. Enhanced Oxidative DNA-Damage in Peritoneal Dialysis Patients via the TXNIP/TRX Axis. Antioxidants (Basel) . 2022 Jun 6;11(6):1124.

Schricker S, Oberacker T, Fritz P, Ketteler M, Alscher MD, Schanz M. Peritoneal Expression of SGLT-2, GLUT1, and GLUT3 in Peritoneal Dialysis Patients. Kidney Blood Press Res. 2022;47(2):125-134.

Ketteler M, Wiecek A, Rosenkranz AR, Pasch A, Rekowski J, Hellmann B, Karus M, Ammer R. Efficacy and Safety of a Novel Nicotinamide Modified-Release Formulation in the Treatment of Refractory Hyperphosphatemia in Patients Receiving Hemodialysis-A Randomized Clinical Trial. Kidney Int Rep. 2021 Dec 19;6(3):594-604.

Neri L, Kreuzberg U, Bellocchio F, Brancaccio D, Barbieri C, Canaud B, Stuard S, Ketteler M. Detecting high-risk chronic kidney disease-mineral bone disorder phenotypes among patients on dialysis: a historical cohort study. Nephrol Dial Transplant. 2019 Apr 1;34(4):682-691.

Education and Professional Career

2019 - present

Department Head of General Internal Medicine and Nephrology / Geriatrics at the Robert-Bosch-Krankenhaus Stuttgart, Germany

2007 – 2019

Division Chief of Nephrology, Klinikum Coburg, and Head of KfH-Nierenzentrum Coburg, Germany

2000 – 2007

Assistant Professor, Consultant (Nephrology/Internal Medicine) at the Department of Nephrology and Clinical Immunology, University Hospital Aachen, Germany

1994 – 2000

Residency/Clinical Fellowship at the Department of Endocrinology, Nephrology and Rheumatology, University Hospital Benjamin Franklin, Charité Berlin, Germany

1992 – 1994

Post-Doctoral Fellowship (DFG) at the Division of Nephrology, University of Utah Health Sciences Center, Utah, USA

1989 – 1992

Internship and Residency at the Department of Nephrology and Hypertension, University Hospital Steglitz, Free University Berlin, Germany

1989

M.D. degree, University of Heidelberg, Germany

Professional Memberships

American Society of Nephrology (ASN)
International Society of Nephrology (ISN)
European Renal Association (ERA)
German Society of Nephrology (DGfN)
German Transplantation Society (DTG)
Council Member of the ERA 2009 – 2018, Congress President of the Annual ERA Congress 2021 in Berlin
Co-Chair of the KDIGO CKD-MBD Guideline Update 2015 – 2017
Board member of the Kidney Health Initiative (KHI) of the American Society of Nephrology (ASN) from 2017 – 2019
Board of Directors of the „Kuratorium für Dialyse und Nierentransplantation“ (KfH e.V.) 2020 – 2026
Executive Committee of the KDIGO Guideline Initiative 2020 - 2022

Scientific Journal Editorial Board Memberships

Nephrology, Dialysis & Transplantation (Theme Editor)
Clincal Nephrology
Journal of Nephrology

Research Group